Home › NDC Lookup › Ingredients › Lidocaine Hydrochloride › 41167-0582-02
Aspercreme with Lidocaine Pain Relieving Creme Lidocaine Hydrochloride 4 g/100g Lotion, 1 tube — NDC 41167-0582-02 package photo

Aspercreme with Lidocaine Pain Relieving Creme Lidocaine Hydrochloride 4 g/100g Lotion, 1 tube

by Chattem, Inc. · 1 TUBE in 1 CARTON (41167-0582-2) / 49.6 g in 1 TUBE
NDC 41167-0582-02
🏷️ FDA NDC (as labeled) 41167-0582-2 billing pads the package segment with a zero
This package
Contains1 tube Pack sizes3 compare ↓
Also comes in: 121 g 41167-0582-01 76.5 g 41167-0582-05
OTC Discontinued Non-controlled ⚠ Discontinued by firm
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Lidocaine Hydrochloride (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Jul 16, 2026 — Presence of Particulate Matter: Hair was found in products (Fresenius Kabi USA, LLC) · FDA recall D-0726-2026
Class II · Jun 8, 2026 — Lack of Assurance of Sterility (Asclemed USA Inc.) · FDA recall D-0658-2026
Class II · Apr 2, 2026 — Lack of Assurance of Sterility (Huons Co., Ltd.) · FDA recall D-0529-2026
Class II · Apr 2, 2026 — Lack of Assurance of Sterility (Huons Co., Ltd.) · FDA recall D-0532-2026
Class II · Nov 30, 2021 — Superpotent Drug: Minimally superpotent (Teligent Pharma, Inc.) · FDA recall D-0296-2022
Class I · Nov 30, 2021 — Superpotent Drug (Teligent Pharma, Inc.) · FDA recall D-0295-2022
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

🆔 Identity & classification

FDA NDC (as labeled) 41167-0582-2
Product NDC 41167-0582
11-digit billing NDC 41167058202
NCPDP billing unit GM — per gram (weight)
UNII V13007Z41A
UPC 0041167058770
Application # M017
SPL Set ID d5da67c3-c2ec-4e3e-abe9-cc862dcfc8bd
Established class (EPC) Amide Local Anesthetic; Antiarrhythmic
Physiologic effect Local Anesthesia
Chemical class Amides
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Discontinued by firm
Marketing start 2014-12-01
Route TOPICAL
Dosage form LOTION
Substance LIDOCAINE HYDROCHLORIDE
Why two NDCs? The FDA registers this code as 41167-0582-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 41167-0582-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerChattem, Inc.
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code41167
First marketedDec 2014
Product typeHuman Otc Drug
Portfolio157 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📗 Our plain-language guide HelloPharmacist
  • It's best to avoid using two lidocaine products at the same time unless your doctor says it's okay. When you use multiple products containing a local anesthetic, the total amount a...
  • Can I use a lidocaine patch and a lidocaine cream at the same time?
  • No — please don't do this. Heat significantly increases how much lidocaine is absorbed through your skin, which can push drug levels in your blood higher than they should be. Stick...
  • Can I put a heating pad on the area where I applied a lidocaine patch?
📖 Read our full Lidocaine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 121 g 76.5 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
GNP Lidocaine Maximum Strength 4 g/100g 46122-0614-10 AMERISOURCE 1 bottle $0.052 — Availability likely —
Leader 4 g/100g 70000-0098-01 Cardinal 1 bottle $0.052 — Availability likely —
Lidocaine HCL 4 g/100g 87137-0101-07 Matthias 1 bottle $0.052 — Availability likely —
Pain and Itch Relief 4% Lidocaine .04 g/40g 00363-3001-24 Walgreens 1 tube — — FDA listed —
Walgreens Pain Relieving Cream 4 g/100g 00363-3037-02 Walgreens 76.5 g — — FDA listed —
Mentholatum Lidocaine Heat 40 mg/mL 10742-8386-01 The 1 bottle — — FDA listed —
Signature Care Lidocaine Cream 40 mg/g 21130-0544-27 Better 1 bottle — — FDA listed —
Kroger Analgesic Analgesic 40 mg/g 30142-0260-01 THE 1 bottle — — FDA listed —
TopCare Pain Relieving Analgesic 40 mg/g 36800-0470-01 Topco 1 bottle — — FDA listed —
Gold Bond Medicated Pain and Itch Relief 4 g/100g 41167-0529-00 Chattem, 1 bottle — — FDA listed —
Aspercreme Lidocaine with Rosemary and Mint 4 g/100g 41167-0565-00 Chattem, 1 bottle — — FDA listed —
Aspercreme Lidocaine with Eucalyptus Essential Oil 4 g/100g 41167-0566-00 Chattem, 1 tube — — FDA listed —
Aspercreme with Lidocaine Pain Relieving Creme 4 g/100gthis 41167-0582-02 Chattem, 1 tube — — Discontinued —
Aspercreme with Lidocaine Foot Pain Creme 4 g/100g 41167-0586-02 Chattem, 1 bottle — — FDA listed —
Aspercreme with Lidocaine Pain Relieving Creme 4 g/100g 41167-0587-07 Chattem, 1 bottle — — FDA listed —
Aspercreme Lidocaine Foot (Diabetic) 4 g/100g 41167-0597-00 Chattem, 1 bottle — — FDA listed —
LidoStat 40 mg/g 44577-0704-02 Clinical 1 tube — — FDA listed —
Equate Pain Relief Cream 4 mg/100mL 49035-0634-97 Walmart, 74 ml — — FDA listed —
Equate Pain Relieving Cream Lidocaine 40 mg/g 49035-0860-01 Wal-Mart 1 bottle — — FDA listed —
CVS Lidocaine Pain Relief Cream 40 mg/g 51316-0379-43 CVS 1 bottle — — FDA listed —
Launch Medical 4 g/100mL 54723-0018-01 Sambria 30 ml — — FDA listed —
BeardedMoney 4 g/100g 54723-0032-01 Sambria 15 g — — FDA listed —
NeuroMed 7 Topical Pain Relief 4 g/100g 54723-0175-22 Sambria 1 tube — — FDA listed —
DG Health Pain Relieving 40 mg/g 55910-0759-01 DOLGENCORP, 1 bottle — — FDA listed —
T-Relief Lidocaine HCL 4% 3.4 g/85g 62795-6050-07 Medinatura 85 g — — FDA listed —
QC Lidocaine Maximum Strength 4 g/100g 63868-0956-01 Chain 1 bottle — — FDA listed —
Pain Itch Relief 4 g/100g 69396-0120-17 Trifecta 1 bottle — — FDA listed —
Lidocaine 4 Percent 4 g/100g 69420-6262-01 SA3, 120 g — — FDA listed —
CVS Health Lidocaine Cream 40 mg/g 69842-0814-77 CVS 1 bottle — — FDA listed —
CVS Lidocaine Maximum Strength 4 g/100g 69842-0921-49 CVS 1 bottle — — FDA listed —
CVS Health Lidocaine Pain Relief 40 mg/g 69842-0980-01 CVS 1 bottle — — FDA listed —
BENGAY Tropical Jasmine 40 mg/g 69968-0614-03 Kenvue 1 tube — — FDA listed —
NumbR-X 4 g/100g 70171-0001-01 Prodigy 1 jar — — FDA listed —
Dr Lido 4 g/100g 70171-0002-01 Prodigy 1 jar — — FDA listed —
Inked Inspired 4 g/100g 70171-0003-01 Prodigy 1 jar — — FDA listed —
Dr Tatty Numbing 4 g/100g 70171-0020-01 Prodigy 1 jar — — FDA listed —
TattooGirl Numbing 4 g/100g 70171-0021-01 Prodigy 1 tube — — FDA listed —
InkKulture Numbing 4 g/100g 70171-0022-01 Prodigy 1 tube — — FDA listed —
Inkorporated Numbing 4 g/100g 70171-0028-01 Prodigy 1 jar — — FDA listed —
Ink Scribd Numbing 4 g/100g 70171-0029-01 Prodigy 1 jar — — FDA listed —
LidoPlus Pain Relief 40 mg/mL 70372-0723-01 Centura 1 tube — — FDA listed —
TheraCare Pain Relieving Lidocaine Cream 4 g/100g 71101-0056-01 Veridian 1 bottle — — FDA listed —
TheraCare Pain Relieving Lidocaine Cream 4 g/100g 71101-0057-01 Veridian 1 bottle — — FDA listed —
HealthWise 4% Lidocaine Cream 2.7 oz 4 g/100g 71101-0102-01 Veridian 1 bottle — — FDA listed —
HealthWise Pain Relief Lidocaine 4 g/100g 71101-0107-47 Veridian 1 bottle — — FDA listed —
HealthWise 4% Lidocaine Cream 4 g/100g 71101-0919-27 Veridian 1 bottle — — FDA listed —
TheraCare 4% Lidocaine Cream 4 g/100g 71101-0930-01 Veridian 1 bottle — — FDA listed —
HealthWise Pain Relief Cream with Lidocaine 4 g/100g 71101-0932-01 Veridian 1 bottle — — FDA listed —
Lidocaine HCl 4 Percent 4 g/100g 71436-0026-01 ARI 120 g — — FDA listed —
Lidozall Plus 4 g/100g 72835-0114-15 V2 15 packets — — FDA listed —
Lidozall Pro 4 g/100g 72835-0445-05 V2 5 packets — — FDA listed —
DCH Pain Relief 4 g/100g 72839-0361-02 Derma 76.5 g — — FDA listed —
SUGAR BRANDS Rescue Pain Relief and Recovery 40 mg/mL 73313-0075-04 Sugar 118 ml — — FDA listed —
Lidocaine HCI 40 mg/g 73352-0204-60 Trifluent 30 g — — FDA listed —
LidoGuard 4 g/100g 73492-0272-30 ALAINA 1 tube — — FDA listed —
TopCare Pain Relieving Cream 40 mg/g 76162-0291-02 Topco 1 bottle — — FDA listed —
Sting Master 40 mg/g 80324-0078-00 Les 1 jar — — FDA listed —
Lidocaine Pain Relief Roll-On 4 g/100mL 82645-0013-97 Pharma 1 bottle — — FDA listed —
Westlake Lidocaine 4 g/100g 82895-0717-50 Westlake 1 bottle — — FDA listed —
Westlake Outdoor Pain and Itch Relieving 40 mg/g 82895-0718-50 WESTLAKE 49 g — — FDA listed —
Lidocore 3.1 g/76.5g 82944-0201-02 iON 1 bottle — — FDA listed —
Gold Bond Maximum Strength Foot Pain Relief 4 g/100g 84714-0427-06 Gold 1 bottle — — FDA listed —
Gold Bond Medicated Pain and Itch Relief 4 g/100g 84714-0529-00 Gold 1 bottle — — FDA listed —
Ikonik Tonik 4 g/100mL 85132-0001-30 IKONIK 1 tube — — FDA listed —
LidoGuard 4 g/100g 85231-0200-30 ViolaCare, 1 tube — — FDA listed —
Alcemiste 4 g/100mL 87087-0001-01 Price 1 jar — — FDA listed —
Tattoo Numbx Numbing Pain Relieving 40 mg/mL 87460-0905-00 Scyberco 1 tube — — FDA listed —
Tattoo Numbing Cream Co 4 g/100g 54723-0023-01 Sambria 1 tube — — FDA listed —
TattooNumb 4 g/100g 54723-0030-01 Sambria 10 g — — FDA listed —
Lidozall 4 g/100g 72835-0004-20 V2 20 packets — — FDA listed —
Arte Maximum strength Numbing Cream 4 g/100g 54723-0024-01 Sambria 30 g — — FDA listed —
Walgreens Burn 4 g/100g 00363-2020-25 WALGREENS 1 tube — — FDA listed —
ZyloRelief 4 g/100g 87450-0208-15 Highmark 5 packets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2014
On the market since
Dec 2014
📍
2026
Currently FDA-listed
12 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Aspercreme with Lidocaine Pain Relieving Creme (this brand).

Top reported reactions

Infusion Site Pain729
Nausea491
Infusion Site Erythema456
Headache438
Dyspnoea426
Diarrhoea423
Fatigue369

Age at onset

Neonate25
Infant21
Child27
Adolescent24
Adult742
Elderly388

Reporter sex

6,526 reports
Male · 35%
Female · 64%
Unknown · 1%

Serious outcomes

Hospitalization2,361
Life-threatening735
Death561
Disabling131
Reports over time (by year) — tap or hover for the count & year
2025 2026 1,366 507
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
41167-0582-01 1 BOTTLE in 1 CARTON (41167-0582-1) / 121 g in 1 BOTTLE 2020-11-01 Active
41167-0582-02 You're viewing this 1 TUBE in 1 CARTON (41167-0582-2) / 49.6 g in 1 TUBE 2014-12-01 Discontinued by firm
41167-0582-05 1 BOTTLE in 1 CARTON (41167-0582-5) / 76.5 g in 1 BOTTLE 2014-12-01 Discontinued by firm

Pack size FAQ

What quantity is in NDC 41167-0582-02?
NDC 41167-0582-02 contains 1 tube — 1 tube in 1 carton / 49.6 g in 1 tube.
What is the difference between NDC 41167-0582-02 and NDC 41167-0582-05?
Both are Aspercreme with Lidocaine Pain Relieving Creme Lidocaine Hydrochloride 4 g/100g Lotion — the drug itself is identical. NDC 41167-0582-02 is the 1 tube package, while NDC 41167-0582-05 is the 1 bottle package.
What NDC number is used to bill for this package of Aspercreme with Lidocaine Pain Relieving Creme Lidocaine Hydrochloride 4 g/100g Lotion?
Bill NDC 41167-0582-02 — the 11-digit billing format is 41167058202. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 41167-0582-2, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 41167-0582-02, written without dashes as 41167058202. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 41167-0582-02, the first segment (41167) is the labeler code FDA assigned to Chattem, Inc.; the middle segment (0582) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (02) identifies this exact package size and type. Together they name one specific package of one specific product.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 1 bottle (41167-0582-01), 1 bottle (41167-0582-05). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Chattem, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 5 words ▾

Uses temporarily relieves minor pain

⏱️ Dosage and Administration 39 words ▾

Directions adults and children over 12 years : apply a thin layer to affected area every 6 to 8 hours, not to exceed 3 applications in a 24 hour period children 12 years and younger : ask a doctor

⚠️ Warnings 151 words ▾

Warnings For external use only Do not use on puncture wounds on large areas of the body or on cut, irritated or swollen skin for more than one week without consulting a doctor When using this product use only as directed. Read and follow all directions and warnings on this carton. do not allow contact with the eyes and mucous membranes do not bandage or apply local heat (such as heating pads) to the area of use do not use at the same time as other topical analgesics Stop use and ask a doctor if condition worsens redness is present irritation develops symptoms persist for more than 7 days or clear up and occur again within a few days If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children and pets . If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 5 words ▾

Active ingredient Lidocaine HCI 4%

🧪 Inactive Ingredients 37 words ▾

Inactive ingredients acrylates/C10-30 alkyl acrylate crosspolymer, alcohol denat. (15%), aloe barbadensis leaf juice, aminomethyl propanol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, cetearyl alcohol, ceteth-20 phosphate, dicetyl phosphate, dimethicone, disodium EDTA, ethylhexylglycerin, glyceryl stearate, methylparaben, steareth-21, water

🎯 Purpose 3 words ▾

Purpose Topical anesthetic

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 41167-0581-00 · Chattem, 41167-0583-05 · Chattem, →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.